glp-1 läkemedel Ny oral GLP-1-analog bättre vid diabetes än semaglutid – Läkartidningen Möjlig fördel med kombo av

Semaglutide delivers superior weight loss results compared to Contrave, with clinical trials showing 15-17% average weight reduction versus 5-9% for the naltrexone/bupropion combination

Overall, the effects of these compounds on fat metabolism, body mass index, lean mass, and insulin sensitivity might show changes in body weight on long-term treatment, yet they are less likely to offer the same results as GLP-1 patches

A notable proportion of patients achieve clinically significant weight loss, with studies indicating that around 40% of adults lost at least 5% of their body weight after one year, and over 15% lost at least 10%

As mentioned earlier, semaglutide GLP-1 tends to produce more significant weight loss compared to liraglutide

This practice allows the skin to recover and reduces the cumulative irritant effect of the adhesive and medication

Table of Contents: How do Liraglutide and Semaglutide GLP-1 differ